# Evaluate the Use of Liposuction and Cell Separation Devices for Autologous Fat (Adipose) Derived Cells to Treat the Symptoms of Erectile Dysfunction

> **NCT01601353** · NA · UNKNOWN · sponsor: **Tissue Genesis** · enrollment: 30 (actual)

## Conditions studied

- Erectile Dysfunction

## Interventions

- **DEVICE:** Tissue Genesis Cell Isolation System

## Key facts

- **NCT ID:** NCT01601353
- **Lead sponsor:** Tissue Genesis
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2012-05
- **Primary completion:** 2018-08
- **Final completion:** 2021-08
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2021-06-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01601353

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01601353, "Evaluate the Use of Liposuction and Cell Separation Devices for Autologous Fat (Adipose) Derived Cells to Treat the Symptoms of Erectile Dysfunction". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01601353. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*